Category Archives: Spinal Cord Injury Treatment

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company has been named one of the Best Places to Work in Massachusetts by the The Boston Business Journal in its eleventh annual regional awards program. The honor recognizes the Companys achievements in creating a positive work environment that attracts and retains employees through a combination of employee satisfaction, working conditions and company culture. InVivo Therapeutics was one of over 400 companies to qualify for consideration based on a two-stage nomination process and the results of employee-satisfaction surveys taken throughout March and April. For years, my biggest concern has been managing rapid growth without experiencing a bottleneck in human resources, said Frank Reynolds, InVivo Chief Executive Officer. In early 2012, we had approximately ten employees, and already we knew that we would be going through intense hiring periods, possibly adding as many as two hundred employees in a quarter. At that point, we partnered with the architects and designers at Kling Stubbins to build a new headquarters in Kendall Square and become the worlds most advanced neurotrauma research center. We now … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that it has issued a call notice for the early exercise of warrants issued to investors on October 26, 2010, November 10, 2010 and December 3, 2010 (the Investor Warrants). Under the terms of the Investor Warrants, the Company has the right to call for an early exercise when the Companys closing stock price equals or exceeds $2.80 per share for twenty consecutive trading days, which occurred on May 2, 2013. Since the start of April 2013, the Company has already received $5.7 million from the exercise of Investor Warrants and expects to receive an additional $10.4 million from the early exercise of the warrants being called. On June 3, 2013, all Investor Warrants that are not exercised will be redeemed and the derivative warrant liability associated with the exercise or redemption of these warrants will be removed from InVivos books. This will eliminate a major impediment towards the uplisting of the Companys stock to a national securities exchange. The Company is also terminating its previously announced offer to exchange with respect to … Continue reading →

Newswise NEW ORLEANS (April 29, 2013) Today, during the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, researchers announced new findings regarding the development of methods to turn human induced pluripotent stem cells (iPSC) into microglia, which could be used for not only research but potentially in treatments for various diseases of the central nervous system (CNS). Microglia are the resident inflammatory cells of the CNS and can modulate the outcomes of a wide range of disorders including trauma, infections, stroke, brain tumors, and various degenerative, inflammatory and psychiatric diseases. However, the effective therapeutic use of microglia demonstrated in various animal CNS disease models currently cannot be translated to patients due to the lack of methods for procuring high-purity patient-specific microglia. Developing a method for obtaining these cells would be highly valuable. In the study Differentiation of Induced Pluripotent Stem Cells to Microglia for Treatment of CNS Diseases, mouse and human iPSCs were generated and sequentially co-cultured on various cell monolayers and in the presence of added growth factors. The microglial identity of the resulting cells was confirmed using fluorescence activated cell sorting analyses, functional assays, gene expression analyses and brain engraftment ability. The study results will be … Continue reading →

Franklin, TN (PRWEB) April 29, 2013 North American Seminars sought out the top rehab professional in the United States while researching the topic of spinal cord rehab. With 6 million people or approximately 1 in 50 people living with some sort of paralysis we knew that this issue effects almost every American in some way. Selina Morgan PT, ATP delivers not only current evidence based evaluation and treatment techniques for Spinal Cord Injury, but an overwhelming compassion for this population. Filming two young adults with paralysis conveys the difficulty, challenges and rewards of working with this population. This film is a unique physical therapy continuing education program featuring a paraplegic and a quadriplegic performing specific rehab activities. As a PT continuing education online course, North American Seminars applied the content in the film to evidence based clinical information. This online continuing education course for PT and OT discusses the following areas of Spinal Cord Rehab: In addition, extensive instruction in the continuing education online course for PT and OT discusses Manual Muscle Testing including: Approved online continuing education for PT and PTA This course meets the continuing education requirements for physical therapists in the States of California, Illinois, New York, … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that CEO Frank Reynolds is scheduled to appear live in New York City on FOX Business Networks Varney & Company on Tuesday, April 30th at approximately 10:25am ET. Varney & Company is a program hosted by veteran business journalist Stuart Varney that airs weekdays from 9:20am to 11:00am ET, giving over two million viewers the 411 on Wall Street. InVivo Therapeutics has pioneered a treatment that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after traumatic SCI. On the show, Reynolds will discuss this first product, the upcoming pilot study, and the platform the Company has built for developing new treatment options for a range of neurotrauma conditions tapping a more than $23 billion market opportunity. Recently, the U.S. Food and Drug Administration (FDA) granted two approvals to the Company, the first for Humanitarian Use Device (HUD) designation, which the Company believes will expedite the products path to market, and the second to approve the … Continue reading →

BANGKOK--(BUSINESS WIRE)-- Vejthani Hospital Bangkok offers Spinal Injury Treatment to solve your spine problem at Vejthani spine center in Thailand. We will analyze for the appropriate care tailored to the needs of each patient suffering from spinal injury. A spinal cord injury (SCI) refers to any injury to the spinal cord that is caused by trauma instead of disease. Depending on where the spinal cord and nerve roots are damaged, the symptoms can vary widely, from pain to paralysis to incontinence. Spinal cord injuries are described at various levels of "incomplete", which can vary from having no effect on the patient to a "complete" injury which means a total loss of function. Spinal injury can occur without trauma. Many people suffer transient loss of function ("stingers") in sports accidents or pain in whiplash of the neck without neurological loss and relatively few of these suffer spinal cord injury sufficient to warrant hospitalization. Treatment of spinal cord injuries starts with restraining the spine and controlling inflammation to prevent further damage. The actual treatment can vary widely depending on the location and extent of the injury. In many cases, spinal cord injuries require substantial physical therapy and rehabilitation, especially if the patient's … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of neurotrauma conditions, today announced that CEO Frank Reynolds is scheduled to appear live in Toronto on Business News Networks (BNNTV) The Close on Monday, April 29th at approximately 4:50pm ET. BNN is Canadas only all business and financial news channel. The Close is a weekday program anchored by Michael Hainsworth that airs from 3:30pm to 5:00pm ET and guides the viewer through the vital last half-hour of trading, zooms in on earnings reports and prepares the investor for the next trading day. InVivo Therapeutics has pioneered a range of biodegradable devices utilizing biocompatible polymers that provide structural support to damaged nervous system tissue. Preventing tissue from scarring results in improved prognosis, and improved functional recovery after traumatic spinal cord injury (SCI). Recently, the U.S. Food and Drug Administration (FDA) granted two approvals to InVivo, the first for Humanitarian Use Device (HUD) designation, which the Company believes will expedite the SCI product to market, and the second approval permits the Company to begin a first-in-man clinical trial. Weve leveraged our materials to create products for multiple neurotrauma conditions that exist outside of the spinal … Continue reading →

Wednesday is World Meningitis Day, dedicated to raising awareness about this disease. Worldwide, more than 1.7 million people suffer from meningitis, a sometimes treatable and often preventabledisease. Meningitis refers to inflammation of the membranes covering the brain and spinal cord, which may be caused by bacteria, viruses, fungi, parasites, physical injury, cancer and certain drugs. If you have meningitis, you may have one or more of the following symptoms: fever, headache, stiff neck, nausea and vomiting, and altered mentalstatus. Seek medical care if you suspect meningitis because the treatment, severity and potential outcomes vary depending on the You have viewed 20 free articles or blogs allowed within a 30-day period. FREE registration is now required for uninterrupted access. S-R Media, The Spokesman-Review and Spokesman.com are happy to assist you. Contact Customer Service by email or call 800-338-8801 Wednesday is World Meningitis Day, dedicated to raising awareness about this disease. Worldwide, more than 1.7 million people suffer from meningitis, a sometimes treatable and often preventabledisease. Meningitis refers to inflammation of the membranes covering the brain and spinal cord, which may be caused by bacteria, viruses, fungi, parasites, physical injury, cancer and certain drugs. If you have meningitis, you may have one … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that John A. McCarthy, Chief Executive Officer at CryoXtract, has joined InVivos Board of Directors. McCarthy has also been appointed as Chair of the Boards Audit committee, and has become a member of the Governance, Nominating and Compensation committee. Weve turned the corner on development and were full steam ahead on commercialization for multiple products. We expect that two 510(k) neurological devices will enter the market by the end of 2014. In the near-term, were focused on establishing long-term partnerships to bring these products to market. We spent 2012 building our operations team, and well spend part of 2013 putting a Board of Directors in place that has extensive deal making experience on Wall Street, said Frank Reynolds, InVivos Chief Executive Officer. InVivo has pioneered a neurological technology platform utilizing a variety of biocompatible polymer-based devices to provide structural support to damaged nervous system tissue in order to spare tissue from scarring while improving functional recovery and prognosis after a traumatic injury. InVivos first product for acute spinal cord injury will begin human … Continue reading →

Trooper injured in chase transported to Shepherd Center with spinal injury Published April 18th, 2013 3:07 pm Trooper James C. Lawson, 41, of Gate City Related: Suspect in Scott County chase faces additional charges ATLANTA -- A Virginia State Police trooper who was seriously injured during a high-speed pursuit in Scott County last week was transferred today to Shepherd Center in Atlanta for further treatment on a spinal chord injury he sustained. According to the hospital, Trooper James C. Lawson, 41, of Gate City, was admitted to the Shepherd Center's Spinal Cord Injury unit for evaluation, care and observation. Once doctors have determined a proper treatment plan for Lawson, he will begin a rigorous rehabilitation program under the guidance of a full team of specialists, a Shepherd Center spokeswoman said. Prior to his transfer Thursday, Lawson had been receiving treatment at Holston Valley Medical Center in Kingsport since his April 9 wreck. Lawson was injured during a high-speed pursuit through Scott County. The suspect in the chase, Jason Byrns, 33, of Kingsport, allegedly rammed Lawson's cruiser at one point during the pursuit on Daniel Boone Road, causing it to hit a parked truck head on. Lawson had to be transported … Continue reading →